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Abstract 
Effective visual communication is a core competency for pharmacometricians, statisticians, and 
more generally any quantitative scientist. It is essential in every step of a quantitative workflow, 
from scoping to execution and communicating results and conclusions. With this competency, we 
can better understand data and influence decisions towards appropriate actions. Without it, we 
can fool ourselves and others and pave the way to wrong conclusions and actions. The goal of 
this tutorial is to convey this competency. We posit three laws of effective visual communication 
for the quantitative scientist: have a clear purpose, show the data clearly, and make the message 
obvious. A concise “Cheat Sheet”, available on https://graphicsprinciples.github.io, distills more 
granular recommendations for everyday practical use. Finally, these laws and recommendations 
are illustrated in four case studies. 
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TUTORIAL  
Effective visual communication for the quantitative scientist 
Marc Vandemeulebroecke1, Mark Baillie1, Alison Margolskee2, Baldur Magnusson1 
Effective visual communication is a core competency for pharmacometricians, statisticians, and 
more generally any quantitative scientist. It is essential in every step of a quantitative workflow, from 
scoping to execution and communicating results and conclusions. With this competency, we can 
better understand data and influence decisions towards appropriate actions. Without it, we can fool 
ourselves and others and pave the way to wrong conclusions and actions. The goal of this tutorial 
is to convey this competency. We posit three laws of effective visual communication for the 
quantitative scientist: have a clear purpose, show the data clearly, and make the message obvious. 
A concise “Cheat Sheet”, available on https://graphicsprinciples.github.io, distills more granular 
recommendations for everyday practical use. Finally, these laws and recommendations are 
illustrated in four case studies. 
INTRODUCTION 
The goal of quantitative science is to facilitate 
informed decisions and actions through a data-
driven understanding of complex scientific 
questions. It is the role of any quantitative scientist 
(pharmacometrician, statistician, econometrician, 
etc.) to support this goal through (1) appropriate 
quantitative methods (experimental design, 
statistical models, etc.) and (2) effective 
communication of results. There should be no 
conflict between technical and communicative skills 
– on the contrary: both of these aspects work in 
concert; either one without the other is not sufficient. 
Often, however, scientists focus on the former and 
neglect the latter, and sophisticated investigations 
remain without impact.1 The goal of this tutorial is to 
help close this gap. 
Scientific influence relies on effective 
communication,2 and visual communication is one of 
the most effective channels of communication. 
Quoting Chambers et al,3 “there is no single 
statistical tool that is as powerful as a well‐chosen 
graph”. Indeed, effective visual communication is a 
core competency for the quantitative scientist: he or 
she must not only “get the question right” 
(understand contextual subject matter) and “get the 
methods right” (technical expertise), but also “get the 
message right”. 
Visualization and the use of graphics can help at 
every stage of a quantitative workflow, from the very 
first data explorations to the final communication of 
conclusions and recommendations. For example, 
we often switch across different modes of working, 
from learning to confirming,4 or from the “subjective” 
to the “objective” (see also Gelman and Hennig5). 
Effective visualization can help in all of these modes; 
see for example Gabry et al6 for a demonstration in 
a Bayesian workflow. In drug development, visual 
communication is required at all stages from 
designing, analyzing and reporting clinical trials, to 
communicating results and supporting subsequent 
decision-making. The role of the quantitative 
scientist in this process is to ensure that relevant 
information (concepts, assumptions, patterns, 
trends, signals, conclusions) is clearly described and 
easy to interpret. For this, we must understand the 
laws and principles of effective visual 
communication, like the grammar of a (visual) 
language.7 
If we get this right, we will be more successful in 
the scoping (e.g. visually clarifying the research 
question), execution (e.g. finding patterns in data), 
and communication (displaying results and 
conclusions) of our work. We can find important 
information in complex data and help people 
understand it. We can positively influence decisions 
and actions. We can create trust, partnership and 
engagement in cross-functional teams and 
audiences. We can increase our personal 
effectiveness. However, if we fail, we can fool 
ourselves and others. We can fail to see patterns in 
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inappropriate displays. We can confuse teams, 
detract from the message, and pave the way to 
wrong conclusions and decisions.8  
Much work has been done on this theme. 
Tukey,9,10 Tufte11 and Cleveland12 laid the 
foundations for good quantitative graphics. Amit et 
al,13 Bradstreet,14 Cabanski et al,8 Donahue,15 
Doumont,16,17 Duke et al,18 Few,19 Gordon and 
Finch,1 Krause and O'Connell,20 Matange,21 Nolan 
and Perrett,22 Nussbaumer Knaflic,23 Robbins,24 
Vandemeulebroecke et al,25 Wainer,26 Wong,27 and 
Wong28 have all fostered an intelligent and impactful 
use of visual communication and graphics. 
Collaborative initiatives such as CTSpedia29 have 
emerged. Importantly, the theme extends beyond 
technical “tips and tricks” for good graphics. More 
fundamentally, it includes the focus on the right 
purpose, scientific question, situation and audience. 
With this in mind, it is the goal of this tutorial to distill 
and convey the main principles of effective visual 
communication for the quantitative scientist in 
simple, useful, and actionable terms.  
The remainder of this tutorial is structured as 
follows. In Section 2 we posit three laws of visual 
communication for the quantitative scientist. Section 
3 focuses on more granular recommendations for 
good visual display, conveniently compiled in a 
single page reference sheet. Complete use cases 
are provided in Section 4 to illustrate the application 
of these laws and recommendations in practice. 
Section 5 closes with a discussion. While most of the 
content is inspired by our work in pharmaceutical 
development, the same principles apply in any 
quantitative science. 
 
THE THREE LAWS OF VISUAL 
COMMUNICATION FOR THE 
QUANTITATIVE SCIENTIST 
In quantitative sciences, effective visual 
communication follows three laws: 
1. Have a clear purpose 
2. Show the data clearly 
3. Make the message obvious 
These three laws correspond to the three main 
ingredients of any quantitative work: purpose, data, 
and message. Getting these right leads to success; 
failing in any of them leads to overall failure. In the 
next subsections, we discuss each of these laws in 
turn.  
 
Law 1: Have a clear purpose 
Why?30,31 What is the purpose of this display or that 
communication? Doumont17 states this as the 
“zeroth law” of professional communication, “a 
principle so obvious that it had long been 
overlooked”. Be clear and explicit about what you 
want to achieve. Is it to explore some data, to convey 
an inferential analysis, to deliver a message, 
convince an audience, or support a decision? It may 
be a mixture of these – for example, even seemingly 
simple exploratory plots should serve some 
(perhaps implicit) decision (e.g. on how to explore 
further). Every graph, and more generally every 
communication, must be tailored to its specific 
purpose. 
It helps to carve out the scientific question you 
are trying to address, ideally in discussion with 
partners, and to write it down explicitly. Try not to 
look at any data before. This is the concept of 
“question-based visualizations”:25 let the scientific 
question determine what data to display and how. 
(For example, combine data from different domains 
if it helps address the question effectively. Do not 
only produce standard outputs by data domain – a 
display should be determined by the question it 
addresses, not by the way the data is organized.) As 
Diggle32 put it, we “analyze problems, not data”. This 
does not mean that the question could not be refined 
after seeing the data. We may well iterate over the 
problem space and the solution space – as long as 
we do it consciously. Senn33 illustrates many 
examples of wrongly framed research questions. A 
common one is to focus on the wrong comparison, 
such as comparing a post-treatment value to the 
corresponding baseline value instead of to the value 
under a control treatment. Most quantitative graphs 
display comparisons,34 and it always helps to ask 
“compared to what?”.11 If the comparison is not clear 
to the author, it will also not be clear to the reader. 
Part of this first law (and of the third, see below) 
is also to be clear about your audience. Then, to 
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adapt to your audience. Do not assume it will adapt 
to you. You cannot control your audience, but you 
can control what information and messages you 
deliver to it, and how. Is your audience just you 
(trying to see patterns in data), you in a few years 
(trying to remember what you did), quantitative 
experts such as your peers (interested in your 
methods), subject matter experts (eager for your 
main message), decision-makers (headlines only), 
or a mixture of these? Your visual communication 
will need to be different accordingly. Your 
communication (plot, presentation, report) is for the 
audience, not for you. 
Clarity on the purpose and the scientific question 
of interest will help choose appropriate quantitative 
methods to address them. This, plus clarity on your 
audience, will help define the key messages and 
how to deliver them. (On the aspect of delivery see 
also Law 3 below.) 
Of note, this first law is so important that it may 
occasionally defy other good principles. If your 
primary goal is to catch attention, then you may 
choose an iconic graphical representation that does 
this well, even if it violates some of the 
recommendations given further below.35 However, 
you should never distort the data. 
 
Law 2: Show the data clearly 
This is Tufte’s11 maxim: “Above all else, show the 
data”. Show it accurately and clearly. This law has 
several faces: 
Simplify! “Simplify to clarify”.36 It is the prime task 
of quantitative scientists to make the complex 
simple: reveal structure in data through models, 
make inference through analyses, distill and convey 
conclusions through (visual) communication. 
Choose the simplest appropriate graph type; prefer 
familiar designs over fancy ones (see also the 
Cleveland-McGill effectiveness ranking in Law 3 
below). Avoid fake dimensions. Make your plot “as 
simple as it can be, but not simpler” (attributed to 
Albert Einstein; also “Occam’s razor” or the law of 
parsimony). “Understand, edit and simplify the 
information and design with your readers in mind”.28 
Do not be confused: it is hard to make things simple. 
This is an iterative process: “edit and revise”,11 and 
repeat.  
Figure 1: Law 2, show the data clearly. The pie and donut charts in panels A and B make it difficult to see the order of magnitude 
of some of the segments. The eye needs to compare areas, bent lengths (of the contour) or angles, graphical attributes that are 
not easily decoded. The donut chart even omits the angles. The mosaic plot in panel C only relies on areas; again it is hard to tell 
the order of magnitude. It is better to use lengths with a common baseline or positions on a common scale, such as in a barchart 
or dotplot (see Cleveland-McGill effectiveness ranking in Law 3). The barchart in panel D however introduces a fake dimension, 
which is unnecessary and makes it hard to decode the numerical values from the height of the bars. Panels E and F are 
appropriately simple and show the data clearly. They also order the data by magnitude to aid comparison even further. The dotplot 
in panel F uses minimal amount of ink and draws the eye to the position of the dots; it is the most effective way of displaying this 
data. 
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Maximize the data-to-ink ratio (also “data density 
index”11) within reason. Maximize the signal over the 
noise by removing the noise: remove anything that 
distracts from the purpose of the graph. Nothing is 
neutral: the choice of symbols or colors, 
background, fonts, line style, annotations. These 
elements are noise if they do not serve a clear 
purpose. Choose them wisely and parsimoniously; 
make the data stand out. Do not trust defaults in 
graphical software packages. Often, intelligent use 
of white space can structure a display better than a 
lot of ink. (The same holds for tables: these are often 
most effectively structured by reserving black lines 
for the horizontal direction and using simple 
alignment in the vertical direction.) Never clutter your 
graph with “chart junk”.37  
Display the relevant data directly. In a 
quantitative workflow, this often means to look at the 
raw data and not just rely on summary statistics. 
Cabanski8 illustrates this with nine datasets that 
show completely different patterns despite identical 
marginal means, standard deviations and correlation 
coefficients (see also Anscombe38 and Matejka and 
Fitzmaurice39). Ask yourself what is the best way of 
summarizing the relevant features of the data; it may 
not be the mean +/- standard error. When fitting a 
(statistical, compartmental, mechanistic etc.) model 
to the data to draw inference or make predictions, 
model-derived quantities may be the relevant data to 
display. In this case a plot of the raw data may be 
misleading if it does not account for important 
covariates. In a final communication, display 
concisely what best supports your message (see 
also below, Law 3). 
Figure 1 illustrates some aspects of this second 
law. Wainer26 has turned this law around, noting that 
“methods for displaying data badly have been 
developed for many years, and a wide variety of 
interesting and inventive schemes have emerged”. 
He provides 12 highly amusing rules for “how to 
display data badly”, with striking examples. He then 
concludes more seriously: “The rules for good 
display are quite simple. Examine the data carefully 
enough to know what they have to say, and then let 
them say it with a minimum of adornment. Do this 
while following reasonable regularity practices in the 
depiction of scale, and label clearly and fully.” 
Law 3: Make the message obvious 
If the second law focused on the data (with a 
tendency to reduce noise), then the third is all about 
the message (and amplifying the signal). This 
assumes that you do have a message to tell, and 
that this message is clear at least to yourself. If there 
is any doubt on this, return to the first law. 
The third law mandates to make your message 
as obvious as possible. Quoting Krzywinski and 
Cairo,40 “inviting readers to draw their own 
conclusions is risky”. Do not only make your 
message easy to get. Make it impossible to miss. 
This extends beyond graphical elements and 
involves all aspects of communication. 
Clarity on your audience, mentioned already in 
the first law, is also a prerequisite for the third. It is 
needed for carving out the message to tell (Law 1) 
and for adapting its way of delivery (Law 3).  
Figure 2: The power of pre-attentive processing. In the top row, 
one data point is marked by a different symbol (left) or color 
(right). Discerning the different symbol requires attention, while 
the different color “jumps out” pre-attentively. In the bottom row, 
left panel, we are drawn to a comparison of lengths. In the right 
panel, we introduce color to draw the eye to the bottom two bars 
first. While length is already a strong pre-attentive attribute, color 
is even stronger. We can use this to guide the viewers’ attention 
through a plot and let them follow the story we want to convey. 
 Under Review 
Specific examples for the third law include the 
following: 
• Choose wisely how to encode the data you 
display. Color and area are good for drawing 
attention, but a viewer can decode positions on 
a common scale much more easily and 
accurately. Consider the effectiveness ranking of 
graphical attributes for encoding numerical 
values, as proposed by Cleveland and 
McGill12,41-44 (see also Cairo,45 Munzner,46 and 
Heer and Bostock47). See Figure 4 for a 
representation of this ranking.  
• Exploit pre-attentive processing as much as 
possible.19, 48 Some graphical features “jump to 
the eye” while others require careful inspection. 
Consider this in your choice of how to encode the 
data (Cleveland-McGill effectiveness ranking, 
see above) and in your choice of symbols, 
colors, line types etc. See Figure 2 for an 
illustration. 
• Avoid mental arithmetic. If differences or ratios 
are the main interest, show them directly. If both 
raw values and differences are of interest, 
consider showing both. 
• Exploit the principles of visual grouping.49 
Graphical entities are most effectively grouped 
by enclosure, connection, proximity and 
similarity (in this order). That is, similar objects 
are perceived as belonging together, as are 
objects close to each other, connected by lines, 
or enclosed in a common subspace. See Figure 
3 for an illustration: these mechanisms can 
provide contextual information to a plot in a 
simple yet powerful way. 
• Minimize the viewer’s eye movement. Place 
elements that are to be compared close to each 
other. Prefer direct labelling over a legend. See 
also Figure 5. 
• Draw the reader’s attention to the main points. 
Use appropriate graphical features (e.g. bold or 
colored highlighting, reference lines, circling 
etc.). Follow up with explicit labelling (e.g. 
“treatment A outperforms treatment B by X%”). 
• Add meaningful information to a graph to tell the 
whole story. E.g., include reference lines, 
benchmark effects, inferences etc. 
• Use effective redundancy. Convey the same 
message through multiple channels, to amplify it 
and give the audience a second chance to get it. 
Use words and pictures in unison.16 E.g., in 
addition to showing the data, consider 
annotating the “good” or “bad” axis direction, and 
state what is seen in plain words. Do not confuse 
redundancy (pointlessly cluttering the graph) 
with effective redundancy (conveying a message 
through multiple complementary channels). 
• Let every plot stand on its own. Use informative 
labels and captions, and explain abbreviations. 
Do not require the reader to search through text 
in order to understand a figure. 
• Always add a title to your plot. Phrase it as a 
conclusion, not a description (e.g. “plasma 
concentration depends on body weight” rather 
than “plot of plasma concentration vs. body 
weight”).   
Figure 3: The principles of visual grouping: enclosure, connection, proximity and similarity. The first panel shows two groups of 
points, identified by similarity (of plot symbols). Here, proximity is a consequence of the data display and cannot be chosen 
deliberately. The second panel introduces color to further enhance the grouping by similarity (using effective redundancy and pre-
attentive processing). The third panel groups the points even more effectively by connecting lines (in addition to the plot symbols 
and colors). Special attention is drawn to a group of points by an enclosing ellipse. 
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Figure 4: Selecting the right base graph; effectiveness ranking. A conscious choice of the most appropriate graph type is an 
essential step towards any good data display. Typical examples are illustrated here. The Cleveland‐McGill effectiveness ranking of 
graphical attributes12,41-44 posits that numbers are most effectively encoded by position or length, less effectively by angle or area, 
and least effectively by color hue or volume. Reproduced from Margolskee et al50 with permission. 
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THE GRAPHICS PRINCIPLES CHEAT 
SHEET 
The three laws outlined above provide overarching 
principled advice, and should serve as a guiding star 
towards effective visual communication for the 
quantitative scientist. To further ease their 
implementation in practice, it helps to distill even 
more detailed recommendations and to illustrate 
them concretely. 
To this end, we have introduced the Graphics 
Principles Cheat Sheet.25,50 This single-page 
reference sheet is an integral part of this tutorial. It 
was carefully designed as a concise and accessible 
resource for everyday practical use. Yet, it draws 
from a wide range of sources.7,9-12,15,16,18-20,24,26-28,41-47 
We hope that it proves useful for putting the three 
laws into practice. 
We highlight major parts of the Cheat Sheet in 
Figures 4-6. The full version is available on 
https://graphicsprinciples.github.io, along with 
corresponding programming code in R.51 Figure 4 
exemplifies the conscious choice of the right base 
graph, an essential step towards any good data 
display. The same figure also illustrates the 
Cleveland‐McGill effectiveness ranking of graphical 
Figure 5: Facilitating comparisons; color for emphasis or distinction. Most quantitative graphs display comparisons.34 Comparisons 
can be facilitated by the effective use of proximity, by making visual inspections easy, and by reducing mental arithmetic. Color is 
a powerful stimulus. It is effective for drawing attention and organizing a narrative, but it should be used with caution and restraint. 
Reproduced from Margolskee et al50 with permission. 
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attributes (see Law 3 in Section 2). According to this 
ranking, numbers are most effectively encoded by 
position or length, less effectively by angle or area, 
and least effectively by color hue or volume. Figure 
5 provides recommendations for facilitating 
comparisons and an effective use of color. Finally, 
Figure 6 shows some advice for displaying data 
more clearly and enhancing legibility and clarity of 
the narrative. 
 
Figure 6: Implementation considerations; legibility and clarity. Various tips and tricks for displaying data more clearly. Effective 
graphs stand on their own; they include all necessary elements for the intended narrative. Their implementation, graphical design, 
and typography support legibility. Reproduced from Margolskee et al50 with permission. 
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CASE STUDIES 
We now apply the laws and recommendations from 
the previous two sections in four short case studies, 
to illustrate their use in practice. The case studies 
are inspired by common examples from a 
pharmacometrician’s (or medical statistician’s) work. 
The same principles apply in any quantitative 
science. While the case studies resemble realistic 
scenarios, the data used in generating the graphs 
are simulated and do not represent any particular 
drug or trial. Details on how these case studies were 
generated (with programming code in R) are 
included in the online appendix. 
  
Case study 1: Exploratory exposure-
response analysis 
This case study illustrates the importance of 
understanding the scientific context when exploring 
data graphically. An exploratory data analysis is 
more than just “plotting data”; it can lead to a deeper 
understanding and inform next steps.6,52 However, 
like an analysis that is poorly thought through, a 
poorly implemented graph can also deceive. 
Consider an inhaled drug intended to improve 
lung function, with the target site of action in the lung. 
The drug is also absorbed systemically from the 
lung. Suppose that the team wants to fine-tune the 
choice of a recommended dose. A typical starting 
point for this question is often a plot of the response 
variable of interest against a summary measure of 
plasma concentration (e.g. the area under the 
concentration time curve, AUC). Figure 7A shows 
such a plot, generated using the default settings of 
the R package ggplot2.53 
In terms of good graphical principles, this plot 
leaves a fair bit to be desired. Several improvements 
are warranted, including proper axis scaling, 
gridlines, annotation, font size, etc. One particularly 
egregious issue is the lack of care in selecting axis 
labels, leaving programming labels for the plotted 
variables (presumably only then to make the effort of 
explaining them in a caption). An improved version 
is shown in Figure 7B, addressing many of these 
formatting issues. With an added LOESS 
smoother,54 we see a positive non-linear trend, 
suggesting a shallow sigmoidal exposure-response 
relationship. 
It is tempting, especially when presented with a 
suboptimal graph, to immediately set about fixing the 
various graphical imperfections and produce a more 
appropriate and visually appealing version of the 
same graph. This is an example of selective 
attention,55 focusing on the detail but overlooking the 
higher purpose of the task (i.e. the “why”). Instead, 
let us now take a step back and revisit this example 
in the context of the first law of visual 
communication: have a clear purpose.  
Why are we conducting an exposure-response 
analysis? Recall that the scientific interest is to fine-
tune the dose, and that the drug is inhaled and acting 
locally in the lung. The implicit assumption of an 
exposure-response analysis is one of causality. 
Here, however, plasma concentration is unlikely to 
be on the causal path from dose to response. What 
would be a better way to address the scientific 
question of interest? 
Consider Figure 7C, where instead of estimating 
an overall trend we now look at the trends within 
dose. Clearly, any apparent trends within dose do 
not follow a consistent pattern across doses. The 
only reason why exposure and response appeared 
associated in the previous two plots is that they 
share a common cause, namely dose. In other 
words, dose is a confounder in those plots, and 
indeed dose is a better predictor of response than 
systemic concentration. We should build a dose-
response model, rather than an exposure-response 
model, and choose a recommended dose based on 
this (and any information on safety and tolerability). 
 
Case study 2: Pharmacokinetic exposure by 
ethnicity 
This case study is inspired by a publication 
comparing the pharmacokinetic exposure of a drug 
in Caucasian vs. Japanese subjects. The same 
single oral dose was administered to all subjects. 
The original graph displays mean +/- standard 
deviations (SD) of the plasma concentration over 
time, grouped by ethnicity (Caucasian or Japanese), 
as in Figure 8A. 
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Figure 7: Exploratory exposure-response analysis. A scatterplot of response vs. exposure (A) is improved by applying good graphical 
principles (B), and fundamentally changed by revisiting the question of interest (C). 
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Figure 8: Pharmacokinetic exposure by ethnicity. A graph that looks fair at first sight (A) reveals important information after two 
simple changes, namely, scaling the y-axis differently and plotting confidence intervals instead of standard deviations (B). Key 
messages are made more obvious by directly plotting the pharmacokinetic parameters of interest (C), or even only their ratios (D). 
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This time, let us start with Law 1. What is the 
purpose of this graph? For drugs that are mainly 
developed in a Caucasian population, Japanese 
drug regulation requires sponsors to investigate 
whether the pharmacokinetics (PK) are similar or 
different between Caucasian and Japanese 
populations. The purpose of this graph is to help 
address this question. Looking at it, we may be 
tempted to say that the PK are reasonably similar. 
But are they really? If they are not, then in what way? 
This leads us to Law 2: show the data clearly. 
The graphical attributes in Figure 8A appear to be 
wisely chosen: the symbols and labels are clear, the 
gridlines are supportive and stay in the background, 
and there is no unnecessary adornment. However, 
at least two things obscure the answer to our 
question of interest. First, the concentrations are 
plotted on a linear scale, which makes it difficult to 
distinguish them at the lower end of the profile. 
Concentrations should be plotted on a logarithmic 
scale because they are log-normally distributed. In 
fact, for concentrations in particular (but not 
generally for any log-normally distributed data) we 
should produce both types of display: one on a log-
linear scale (to assess the elimination phase) and 
one on a linear scale (to see the peak more clearly). 
Second, it is hard to determine whether any 
differences are significant when standard deviations 
are plotted instead of standard errors or confidence 
intervals. Standard deviations show the variation in 
the data; they do not shrink when more data is 
collected. Standard errors show the variation in the 
means. Confidence intervals may be the best choice 
as they directly show the uncertainty about the 
means. 
These issues have been fixed in Figure 8B (we 
only show the log-linear version). To reduce 
cluttering, the ticks at the end of the whiskers have 
also been omitted (non-data ink). If the graph 
displayed more than two profiles, we might consider 
replacing the whiskers by (shaded) confidence 
bands, or separating the graph out in panels or 
“small multiples” (see bottom of the backside of the 
Cheat Sheet on https://graphicsprinciples.github.io). 
From Figure 8B it appears that the higher 
concentrations are not meaningfully different, but the 
elimination phase does differ between the two 
ethnicities. This could also translate to different 
average exposures. That is, based on two simple 
changes in the plot, we now see answers emerging 
for our initial question about PK differences. We see 
them emerging with respect to three key PK 
characteristics: peak, elimination/trough, and overall 
exposure. While (depending on the drug) similarity 
in the peak may be reassuring from a safety point of 
view, a lower overall exposure in Japanese subjects 
could be a concern for efficacy. 
Moving on to Law 3, let us now make the 
message obvious. We could choose a completely 
different graph type to hone in on the message. 
Figure 8C shows the three (non-compartmentally 
derived) quantities Cmax, Ctrough and AUClast with 
95% confidence intervals by ethnicity. Clearly, 
Ctrough and AUC are different between the two 
ethnicities, but Cmax is not. We could derive these 
quantities from a compartmental model fit and 
produce the same plot. Or we could go one step 
further and show directly their geometric mean ratio, 
Japanese vs. Caucasian subjects, as in Figure 8D. 
This last plot answers the initial question most 
succinctly, and its graphical appearance has also 
been further simplified (no frame, minimal gridlines, 
mildly highlighted line of equality), to not distract 
from the message. In practice, Figures 8B, 8C 
and/or 8D together may be most informative, 
covering the time course as well as differences in 
key parameters. 
 
Case study 3: Improving a “waterfall plot” 
This case study illustrates the importance of aligning 
a graph with the scientific question it should address, 
the option of filtering signals through a model, and 
finally the display of a scientific answer in a 
condensed messaging graph. 
Consider a small early development trial, 
randomized and placebo-controlled (2:1 
randomization), with a continuous primary endpoint 
measured at baseline and longitudinally over a 
period of 4 weeks. Lower outcome values are better, 
and there are no dropouts and no missing data. 
Suppose that the team is interested in the effect of 
the drug at the last measurement time point, as it is 
often the case. A common approach in early 
 Under Review 
development trials is to simply plot the observed 
change scores in a so-called “waterfall plot” such as 
Figure 9A. 
To probe Law 1, what is the question addressed 
by this plot? It asks about the treatment effect after 
4 weeks of treatment. Is this the right question? Let 
us assume for a moment that it is. Then a waterfall 
plot is not ideal for addressing it.56 Small treatment 
effects are difficult to discern, especially with an 
unbalanced randomization ratio. The audience must 
observe the distribution of color across the entire plot 
just to determine which treatment is more beneficial; 
this can become even more difficult with a larger 
sample size or more than two treatment groups. In 
Figure 9A, one might see a treatment benefit, but 
how large is it and how certain of it are we? The 
popularity of waterfall plots is a mystery. 
If we insist on week 4 as the only time point of 
interest, we could present overlaid density plots or 
side-by-side boxplots for a better appreciation of the 
difference in distribution between the two treatment 
arms. Figure 9B shows an example with the raw data 
points included, which is a much better alternative to 
Figure 9A. The side-by-side placement facilitates the 
treatment comparison, and the plot is simple, 
familiar and uses minimal ink for what it shows. 
Graphical attributes (colors, font size, etc.) are easily 
readable. 
However, with such rich longitudinal data, it may 
be more informative to ask the question about the 
treatment effect during – not just after – the first 4 
weeks of treatment. This is especially relevant in the 
early, more exploratory development phase (and it 
would be even more relevant if there were dropouts). 
As a rule, the recommended first step is to visualize 
the totality of the data. Figure 9C does this and 
includes means by treatment and time point. We see 
large inter-individual variability and overlap between 
the treatment groups. We also start to get an 
appreciation for the time-course of a mean effect. 
We see linear trajectories of the means over time, 
with the active arm appearing to improve and the 
placebo arm staying fairly constant. We cannot 
exclude that the apparent gap might continue to 
increase beyond 4 weeks of treatment. This plot, 
while doing little more than displaying the raw data, 
is already worth sharing with the project team. It 
facilitates a much richer understanding of the data 
than the previous two plots. It shows the data clearly 
(Law 2). 
Depending on the goal of the analysis, we could 
stop here. But if we want to quantify the treatment 
difference while adjusting for important covariates, 
we should proceed with a statistical model. Based 
on Figure 9C a linear model appears appropriate. 
We fit a linear model with treatment, patient-specific 
intercept and slope, and we now also adjust for the 
baseline value of the primary endpoint and for any 
other important covariates.  We can then visualize 
the data filtered through this model, omitting the raw 
data but displaying longitudinal point estimates and 
some form of uncertainty intervals for both treatment 
groups (Figure 9D). This gets closer to the nature of 
a messaging graph, focusing directly on the results 
of our model. Optionally – and depending on the 
audience! – we could even go one final step further 
and display the treatment difference directly, as in 
Figure 9E. This plot addresses the question about 
the treatment effect over time without requiring any 
mental arithmetic. We can read off approximate 
estimates for the treatment effect, and the level of 
confidence is easily appreciable from the added 
confidence band (which does include zero!). 
Appropriate and parsimonious annotations make the 
message even more obvious (Law 3), also through 
“effectively redundant” information (stating what can 
be seen). 
It is worth emphasizing that this last plot should 
not be the only one generated, and probably not the 
only one shown either. Strongly reduced messaging 
graphs require a robust understanding of the 
underlying data, which can only be built through a 
workflow such as the one described above. Further, 
depending on the situation and the audience, they 
might be challenged as loaded or unscientific. (E.g., 
the apparently perfect linear trend in Figure 9E 
appears “unrealistic”.) It is therefore important to 
ensure and emphasize that this last plot derives from 
a model which (as every model) is intended to 
separate the signal from the noise, and that the 
choice of this model is justified by a thorough 
inspection of the data. 
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Figure 9: Improving a “waterfall plot”. A waterfall plot focusing on the last observed time point (A), common in early development, is 
improved by a side-by-side boxplot (B) which shows the treatment comparison more clearly. Showing the totality of the data during 
the first 4 weeks (C) facilitates an even richer understanding, including a suggested linear trend of the treatment effect over time. 
This may justify the fit of a linear model (D) and ultimately (optionally) a condensed messaging graph on the treatment effect (E) 
based on this fit. 
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Figure 10: Post-hoc subgroup analysis. A project team saw an overall insufficient treatment effect regarding weight loss (A), but a 
seemingly stronger benefit in a subgroup of patients identified by a biologically plausible genetic marker (B). Getting the comparison 
right, however, it becomes clear that the marker, while prognostic for weight loss in general, is not predictive for a treatment effect 
vs. placebo (C). This is made more obvious by displaying the treatment difference directly (D). Finally, we can craft a messaging 
slide suited for conveying this message to a group of executives within seconds (E). 
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Case study 4: Post-hoc subgroup analysis 
Post-hoc exploratory subgroup analyses are 
common especially after borderline or failed clinical 
trials.57 Often the objective of such analyses is to 
understand why the study failed, or to identify a 
subgroup of patients who did show sufficient 
response to the treatment.58,59 In this fourth case 
study we illustrate the challenge of navigating this 
type of analysis. The objective is to present to 
decision-makers a recommendation whether or not 
to proceed with further investigation of a genetic 
marker that may be predictive of response to 
treatment. 
Figure 10A displays the desired effect, 
percentage body weight loss from baseline, for an 
active treatment and a placebo control arm. The 
primary endpoint is 12 weeks after randomization. 
Although the active treatment reduced body weight, 
the average extent of the effect was not considered 
clinically meaningful. However, the team found a 
subgroup of patients identified by a biologically 
plausible genetic marker who appeared to benefit 
more strongly from the compound, as shown in 
Figure 10B.  
At this point we need to intervene. Already the 
first plot did not show the data clearly (Law 2), using 
barely distinguishable plot symbols and huge ticks at 
the end of the error bars, too many ticks on the y-
axis, and – worst offense – visit numbers on the x-
axis (equally spaced!). The second plot, in addition, 
is fundamentally flawed, because it displays the 
wrong comparison (Law 1, wrong scientific 
question). The treatment effect in this trial is weight 
loss under active treatment compared to weight loss 
under placebo, and this subgroup analysis removes 
the placebo arm completely. 
Let us put the placebo group back in, and at the 
same time improve the various graphical 
shortcomings of the plot (using appropriately spaced 
times on the x-axis, distinguishable plot symbols 
etc.). We obtain Figure 10C which displays the 
treatment-by-subgroup interaction over time (and 
clarifies that the error bars are 95% confidence 
intervals). Interestingly, we see some weight loss 
also in the biomarker-positive placebo group, and 
weight gain in the biomarker-negative placebo 
group. The treatment effect (active drug vs. placebo) 
is similar within each biomarker group. In other 
words, the biomarker appears prognostic for weight 
loss (at least under the conditions of this clinical trial 
which may include dietary or exercise advice), but 
not predictive for a treatment effect. Figure 10D 
displays the treatment effect directly, to make it 
obvious that it is the same irrespective of the genetic 
marker (Law 3).  
To complete our objective, we should present 
these results and our recommendation about the 
genetic marker to decision-makers. We need to 
show the results clearly and make the message 
obvious. In this context, the message is that the 
genetic marker is not predictive for a treatment 
effect; whether it is prognostic for weight loss is less 
important. Figure 10D supports our message most 
succinctly. Based on this figure, we finally craft a 
messaging slide that is suited for conveying this 
message in a meeting to a group of executives within 
seconds. 
Figure 10E shows this final slide. Guided by 
Laws 2 and 3, we arrived at this slide by considering 
the following principles and recommendations. 
• Facilitate comparisons. We zoom in on the 
comparison of interest by appropriately 
restricting the y-axis. A reference line at zero 
indicates the position of no treatment effect, and 
a labelled arrow shows the direction of treatment 
benefit. 
• Reduce cognitive load. We use direct labelling 
instead of a legend to identify the two subgroups. 
We select clearly distinguishable colors that also 
carry through to the subgroup labels. 
• Adapt to your audience. We avoid writing the y-
axis label vertically, by placing it above the plot 
and using it as its title. This is to prevent the 
audience from straining to read information 
during the meeting. We spell out that this is a 
treatment comparison (a difference) in terms of 
weight loss. We also reduce the size of the 
symbols representing the point estimates, to 
avoid the audience focusing too much on these 
and too little on the uncertainty intervals.   
• Remove non-data ink. We reduce the number of 
ticks and points displayed on the x- and y-axes. 
They do not convey useful information for a short 
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presentation, as we do not expect the audience 
to extract exact values. The connecting lines are 
pushed to the background by introducing a 
degree of transparency. 
• Effective redundancy. We add a caption that 
spells out what is seen at week 12 (the primary 
endpoint), and we highlight the corresponding 
treatment effect estimates by an enclosing circle 
(a powerful grouping technique to draw 
attention). Finally, we place the main message 
directly as the title of the slide (setting the most 
important word, “not”, in bold), and as subtitle we 
explicitly put our recommendation: “Genetic 
marker does not warrant further investigation.”  
 
DISCUSSION 
Effective visual communication appears obvious, but 
creating it requires skill. The purpose of this tutorial 
was to convey some of this skillset. We have 
proposed three laws of visual communication for the 
quantitative scientist:  
1. Have a clear purpose 
2. Show the data clearly 
3. Make the message obvious 
The first law is about doing the right thing; the two 
others are about doing things right. We have distilled 
a range of more detailed recommendations on the 
Graphics Principles Cheat Sheet,50 a concise 
reference sheet available on 
https://graphicsprinciples.github.io. Finally, we have 
discussed four use cases to illustrate the application 
of these laws and recommendations in practice.    
No system is perfect. First, there is simply no 
tension-free one-size-fits-all approach to visual 
communication: the given laws and 
recommendations may occasionally cause conflict. 
Should we show raw data or summaries? More or 
less detail? Confidence intervals or not? Individual 
treatment effects or only their difference? These and 
other choices depend on the purpose and situation 
of the communication, the audience, and the author. 
Importantly, the format of a display or presentation 
may impose practical constraints (are colors 
available? how much time will I have? etc.). Good 
judgement is always due, and sometimes a 
conscious compromise. 
Second, the distinction between the three given 
laws may be challenged as occasionally blurred: 
• We have already mentioned the need to adapt to 
the audience, which is part of Law 1 (have a clear 
purpose – with respect to a target audience) as 
well as Law 3 (make the message obvious – to a 
specific audience). If your audience does not 
understand your message, do not repeat it in the 
same way (and never louder!). Adapt and find 
other ways to convey it (effective redundancy). 
• Another such general principle is: “do no harm.” 
In medical and bio-ethics (“primum non nocere”) 
it is thought to derive from the oath of 
Hippocrates. But it also applies to graphics and 
visual communication.60 For example, do not get 
carried away by technology (templates, frames, 
animation etc.) that clouds the data (Law 2) or 
draws attention away from the message (Law 3; 
see also Baillie’s and Vandemeulebroecke’s 
comment61 in the discussion of Bowman62). The 
removal of “chart junk” (in Law 2) is another 
example. 
• Bonate31 mandates a principle which may belong 
to Law 1 and Law 3: “don’t be boring”. If you 
engage your audience through clarity, visual 
cues, and perhaps humor, it will be easier for 
them to pay attention and understand your 
message. Your visual communication will 
achieve its purpose. However, if you bore your 
audience with unnecessary detail, an odd visual 
pace, by clouding your main point or by not even 
having one, then it will just turn away.  
• The Cleveland-McGill effectiveness ranking, 
introduced in Law 3, serves Law 2 just as much. 
Third, we may have missed some special 
considerations. For example, we did not say much 
about an appropriate choice of color, considering 
human color perception, psychological 
connotations, color-blindness etc. For further 
information, we refer to Wong,63 Wilke,64 and 
resources such as Munsell65 and ColorBrewer.66  
Despite these limitations, we believe that it helps 
to think of the three proposed laws as major maxims 
for visual communication for the quantitative 
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scientist. Keeping the Graphics Principles Cheat 
Sheet “at your fingertips” may provide additional 
practical support. Finally, our advice is to practice. 
To quote Tufte:11 “Graphical competence demands 
three quite different skills: the substantive, statistical, 
and artistic.” These skills cannot be learned by 
reading an article. Adopt visualization in every part 
of your workflow; make it a habit. Think graphically. 
Use pencil and paper before coding in software.67,68 
Calculate and communicate.68 Test and repeat.   
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